57 studies found for:    Open Studies | "Hyperparathyroidism"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hyperparathyroidism"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pediatric Chronic Kidney Disease Safety and Efficacy
Conditions: Chronic Kidney Disease;   Hyperparathyroidism;   Hyperparathyroidism, Secondary;   Kidney Disease;   Secondary Hyperparathyroidism
Interventions: Drug: cinacalcet capsule;   Drug: placebo capsule;   Drug: cinacalcet tablet;   Drug: placebo tablet
2 Recruiting Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
Conditions: Hyperparathyroidism;   Chronic Kidney Disease
Interventions: Drug: sevelamer carbonate;   Drug: placebo
3 Unknown  Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism
Conditions: Hyperparathyroidism;   Arterial Stiffness
Intervention: Drug: Cinacalcet
4 Recruiting Denosumab in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Interventions: Drug: Denosumab;   Other: Placebo
5 Recruiting Vitamin D Repletion in Primary Hyperparathyroidism
Conditions: Primary Hyperparathyroidism;   Vitamin D Deficiency
Interventions: Dietary Supplement: 50,000 IU Vitamin D3;   Dietary Supplement: 12,000 IU Vitamin D3;   Dietary Supplement: Placebo
6 Recruiting Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism
Conditions: Secondary Hyperparathyroidism;   End Stage Renal Disease;   Parathyroid Hyperplasia
Intervention: Device: Ultrasonic ablation device
7 Recruiting Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Conditions: Primary Hyperparathyroidism;   Hypercalcemia;   Vitamin D Deficiency;   Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D3
8 Recruiting Radius Loading in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
9 Recruiting A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism
Conditions: Secondary Hyperparathyroidism;   End Stage Renal Disease
Intervention:
10 Recruiting Surgical Approach for Primary Hyperparathyroidism in the Elderly
Condition: Multigland Disease in Primary Hyperparathyroidism
Intervention: Procedure: unilateral neck exploration
11 Recruiting Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up
Condition: Primary Hyperparathyroidism
Intervention: Procedure: Parathyroid surgery
12 Recruiting Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
13 Recruiting Safety and Efficacy of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
Conditions: Chronic Kidney Disease;   Secondary Hyperparathyroidism (SHPT);   Vitamin D Insufficiency
Interventions: Drug: CTAP101 30 μg capsules;   Drug: CTAP101 60 μg capsules;   Drug: CTAP101 30 μg sugar pill capsule;   Drug: CTAP101 60 μg sugar pill capsules
14 Not yet recruiting Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: AMG 416;   Drug: placebo
15 Not yet recruiting Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
16 Recruiting 20120230: Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: AMG 416;   Drug: Placebo
17 Recruiting Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
18 Unknown  Lipids Profile in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Intervention:
19 Recruiting A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism
Condition: Secondary Hyperparathyroidism
Intervention: Drug: DP001
20 Recruiting Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
Condition: Secondary Hyperparathyroidism
Interventions: Procedure: Subtotal parathyroidectomy;   Drug: Cinacalcet

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years